港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长全年纯利实现扭亏为盈

智通财经04-01

智通财经APP获悉，康希诺生物(06185)午前涨近10%，截至发稿，涨9.49%，报34.16港元，成交额2834.76万港元。消息方面，康希诺生物发布年度业绩。全年实现营业收入10.59亿人民币元，同比增长28.43%；本公司拥有人应占溢利2787.30万人民币元，同比扭亏为盈。此外，公司发布未来三年股东分红回报规划，明确现金分红优先原则。公告显示，报告期内，业绩增长主要得益于公司核心产品...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2624956661?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-01 11:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624956661","market":"us","top_or_hot":-1,"title":"港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长 全年纯利实现扭亏为盈","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，康希诺生物(06185)午前涨近10%，截至发稿，涨9.49%，报34.16港元，成交额2834.76万港元。消息方面，康希诺生物发布年度业绩。全年实现营业收入10.59亿人民币元，同比增长28.43%；本公司拥有人应占溢利2787.30万人民币元 ，同比扭亏为盈。此外，公司发布未来三年股东分红回报规划，明确现金分红优先原则。公告显示，报告期内，业绩增长主要得益于公司核心产品...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1423810.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长 全年纯利实现扭亏为盈</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长 全年纯利实现扭亏为盈\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-01 11:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1423810.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，康希诺生物(06185)午前涨近10%，截至发稿，涨9.49%，报34.16港元，成交额2834.76万港元。消息方面，康希诺生物发布年度业绩。全年实现营业收入10.59亿人民币元，同比增长28.43%；本公司拥有人应占溢利2787.30万人民币元 ，同比扭亏为盈。此外，公司发布未来三年股东分红回报规划，明确现金分红优先原则。公告显示，报告期内，业绩增长主要得益于公司核心产品...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1423810.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1423810.html","article_id":"2624956661","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2624956661","pubTimestamp":1775015783,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，康希诺生物(06185)午前涨近10%，截至发稿，涨9.49%，报34.16港元，成交额2834.76万港元。消息方面，康希诺生物发布年度业绩。全年实现营业收入10.59亿人民币元，同比增长28.43%；本公司拥有人应占溢利2787.30万人民币元 ，同比扭亏为盈。此外，公司发布未来三年股东分红回报规划，明确现金分红优先原则。公告显示，报告期内，业绩增长主要得益于公司核心产品中国首款四价流脑结合疫苗曼海欣的收入持续增长；公司通过持续践行以创新为核心、以商业化为重点的发展战略，深入推进降本增效，同时优化了产销协同，经营效率持续提升。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159646":"疫苗","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK1515":"抗疫概念","BK1161":"生物科技","BK1191":"制药","BK1574":"生物医药B类股","VXUS":"国际股票ETF-Vanguard","06185":"康希诺生物"},"translate_title":"Changes in Hong Kong stocks | CanSino Biologics (06185) rose nearly 10% before noon, meningococcal vaccine revenue continued to grow, and the annual net profit turned losses into profits","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159646":1.5,"VXUS":1.5,"06185":1.5},"content_text":"智通财经APP获悉，康希诺生物(06185)午前涨近10%，截至发稿，涨9.49%，报34.16港元，成交额2834.76万港元。消息方面，康希诺生物发布年度业绩。全年实现营业收入10.59亿人民币元，同比增长28.43%；本公司拥有人应占溢利2787.30万人民币元 ，同比扭亏为盈。此外，公司发布未来三年股东分红回报规划，明确现金分红优先原则。公告显示，报告期内，业绩增长主要得益于公司核心产品中国首款四价流脑结合疫苗曼海欣的收入持续增长；公司通过持续践行以创新为核心、以商业化为重点的发展战略，深入推进降本增效，同时优化了产销协同，经营效率持续提升。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2624956661","isCrawlerRequest":true}

港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长 全年纯利实现扭亏为盈

精彩评论

港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长全年纯利实现扭亏为盈